WELLS FARGO & COMPANY/MN

Position in CANF — Can-Fite BioPharma Ltd.

CIK 72971 SAN FRANCISCO, CA

Position in CANF

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$175

-$212 QoQ

Shares Held

-52.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 8 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. CANF ranks #384 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	749,528	$372,313,040
2	HALO	Halozyme Therapeutics, Inc.	1,390,428	$108,828,797
3	ALNY	Alnylam Pharmaceuticals, Inc.	310,047	$93,333,446
4	REGN	Regeneron Pharmaceuticals, Inc.	140,802	$87,795,677
5	EXEL	Exelixis, Inc.	717,840	$39,057,673
6	RVMD	Revolution Medicines, Inc.	178,780	$33,481,916
7	ARGX	Argenx SE	34,453	$31,964,458
8	INCY	Incyte Corp	255,064	$28,914,053

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$175	59	-52.8%	Shares	Defined	2026-08-14
2026-03-31	$387	125	-95.0%	Shares	Defined	2026-05-11
2025-12-31	$500	2,500	-7.4%	Shares	Defined	2026-02-13
2025-09-30	$1,674	2,700	0.0%	Shares	Defined	2025-11-13
2025-06-30	$2,835	2,700	0.0%	Shares	Defined	2025-08-14
2025-03-31	$3,996	2,700	+8.0%	Shares	Defined	2025-05-13
2024-12-31	$4,075	2,500	0.0%	Shares	Defined	2025-02-13
2024-09-30	$5,025	2,500	+66.7%	Shares	Defined	2024-11-13
2022-03-31	$1,860	1,500	0.0%	Shares	Defined	2022-05-16
2021-12-31	$1,935	1,500	0.0%	Shares	Defined	2022-02-14
2021-09-30	$2,490	1,500	0.0%	Shares	Defined	2021-11-15
2021-06-30	$3,420	1,500	0.0%	Shares	Defined	2021-08-16
2021-03-31	$3,705	1,500	—	Shares	Defined	2021-05-13
No filing history on record for this holder in this stock.